SCLX CIK: 1820190

Scilex Holding Co

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
23.0
FY22:
29.6
FY23:
46.8
FY24:
41.5
FY25:
38.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
54.9
FY22:
56.9
FY23:
54.5
FY24:
51.4
FY25:
327
Total assets
Change from FY21 to FY25
millions USD
FY21:
77.9
FY22:
86.5
FY23:
101
FY24:
93.0
FY25:
365

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
169
FY22:
44.8
FY23:
250
FY24:
260
FY25:
484
(negative)
Change from FY21 to FY25
millions USD
FY21:
132
FY22:
5.45
FY23:
23.9
FY24:
26.0
FY25:
93.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−224
FY22:
36.2
FY23:
−173
FY24:
−193
FY25:
−208
Total liabilities & equity
Change from FY21 to FY24
millions USD
FY21:
77.9
FY22:
86.5
FY23:
101
FY24:
93.0
FY25:
–

All amounts in millions USD Data source:SEC EDGAR